Mawer Investment Management Ltd. lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 13.8% in the third quarter, HoldingsChannel.com reports. The fund owned 112,030 shares of the healthcare conglomerate’s stock after selling 17,924 shares during the quarter. Mawer Investment Management Ltd.’s holdings in UnitedHealth Group were worth $41,124,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently modified their holdings of the business. City State Bank increased its stake in shares of UnitedHealth Group by 5.6% during the 3rd quarter. City State Bank now owns 471 shares of the healthcare conglomerate’s stock worth $173,000 after purchasing an additional 25 shares in the last quarter. Murphy Pohlad Asset Management LLC lifted its stake in UnitedHealth Group by 0.5% in the 3rd quarter. Murphy Pohlad Asset Management LLC now owns 5,305 shares of the healthcare conglomerate’s stock valued at $1,947,000 after buying an additional 25 shares in the last quarter. LFG Wealth Partners LLC lifted its stake in UnitedHealth Group by 3.3% in the 2nd quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate’s stock valued at $355,000 after buying an additional 27 shares in the last quarter. Synergy Financial Group LTD grew its holdings in UnitedHealth Group by 3.1% during the 2nd quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate’s stock valued at $369,000 after buying an additional 27 shares during the last quarter. Finally, Ares Financial Consulting LLC increased its position in UnitedHealth Group by 7.2% during the second quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock worth $174,000 after buying an additional 28 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities analysts have recently weighed in on UNH shares. DA Davidson set a $512.00 price target on UnitedHealth Group in a report on Tuesday, July 21st. TD Cowen reiterated a “hold” rating and set a $402.00 price objective on shares of UnitedHealth Group in a research report on Thursday, October 15th. Morgan Stanley upped their target price on shares of UnitedHealth Group from $529.00 to $531.00 and gave the company an “overweight” rating in a report on Tuesday, October 27th. Argus raised their price target on shares of UnitedHealth Group from $400.00 to $470.00 and gave the stock a “buy” rating in a research note on Monday, July 20th. Finally, UBS Group reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, October 13th. Twenty investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $463.93.
Read Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Trading Up 0.6%
NYSE:UNH traded up $2.49 during mid-day trading on Friday, reaching $407.62. The company’s stock had a trading volume of 3,467,004 shares, compared to its average volume of 5,162,694. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. The stock has a market cap of $365.23 billion, a P/E ratio of 23.28, a P/E/G ratio of 1.47 and a beta of 0.51. The company’s fifty day simple moving average is $391.36 and its two-hundred day simple moving average is $365.66. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. The company had revenue of $112.72 billion during the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company’s quarterly revenue was down .4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be issued a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s payout ratio is presently 53.00%.
Recent UnitedHealth Group Headlines
Here are a few of the latest headlines about UNH:
- Positive Sentiment: ETF flows were supportive: 51 ETFs bought UNH while nine sold shares on Nov. 11, for reported net ETF buying of $86.8 million. Article: UnitedHealth Sees $86.8 Million in Net ETF Buying
- Positive Sentiment: Recent commentary says analysts remain optimistic, and another article argues the shares may still be below fair value. It cites board changes and a sharper focus on medical-cost management and pricing as factors that could support earnings, though valuation depends on execution. Article: Do Wall Street Analysts Like UnitedHealth Group Stock? Article: UnitedHealth Group Stock Still Looks Below Fair Value After Board Appointment
- Neutral Sentiment: A technical analysis described UNH as consolidating, with neutral momentum and thin volume, suggesting no strong near-term signal from trading activity. Article: UnitedHealth Stock Price Prediction
Insider Buying and Selling
In related news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.19% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
See Also
- Five stocks we like better than UnitedHealth Group
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
